Clinical trial
Rapid Effects Linagliptin on Monocyte Polarization and Endothelial Progenitor Cells in Type 2 Diabetes
NCT01617824
Study timeline
Study start (unknown)2012-09-01Date precision: month
Registry last updated2014-12-19
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetesunresolved
Chronic Renal Failureunresolved
Interventions
LinagliptinDRUG · verified · RxNorm: linagliptin
PlaceboDRUG
Sponsors & collaborators
University of Padovalead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01617824 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.